Street Calls of the Week
General Atlantic (ALN HLTH), L.P., a ten percent owner and director in Alignment Healthcare, Inc. (NASDAQ:ALHC), sold 13,460,000 shares of common stock at a price of $16.01 on September 12, 2025. The transaction amounted to $215,494,600. The sale comes as ALHC shares have surged 45% year-to-date, with the company showing strong revenue growth of nearly 50% in the last twelve months. According to InvestingPro analysis, ALHC is currently trading at high valuation multiples, suggesting careful consideration for potential investors.
Following the sale, General Atlantic (ALN HLTH), L.P. directly holds 30,533,323 shares. The filing also notes that Nicholas Robbert Vorhoff and David C. Hodgson hold shares and restricted stock units for the benefit of General Atlantic Service Company, L.P. With a market capitalization of $3.27 billion, InvestingPro data indicates that analysts expect the company to achieve profitability this year, marking a significant milestone in its growth trajectory.
In other recent news, Alignment Healthcare reported its second-quarter 2025 earnings, showcasing a remarkable earnings per share of $0.07, far exceeding the anticipated -$0.07. The company’s revenue reached $1 billion, surpassing the forecast of $960.51 million, highlighting strong business growth. Following this solid earnings report, Barclays upgraded Alignment Healthcare’s stock rating from Underweight to Equalweight, raising its price target from $9.00 to $13.00. Additionally, KeyBanc upgraded the company’s stock from Sector Weight to Overweight, citing a positive growth outlook and a price target of $21.00.
KeyBanc noted that Alignment Healthcare is emerging as a more effective model in the healthcare sector, with improvements in hospital utilization and reinvestment into member benefits. Furthermore, Alignment Healthcare announced the appointment of Matt Eyles as executive vice president of government and business strategy. In this role, Eyles will focus on enhancing the company’s engagement in healthcare policy and leading business planning efforts. These developments reflect Alignment Healthcare’s strategic initiatives and recent performance advancements.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.